Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03271463 · ClinicalTrials.gov registry record

Assessing Leg Control in People With Chronic Stroke

A clinical trial of Chronic Stroke, sponsored by University of Minnesota.

Completed
Registry status
16
Enrollment target
1
Study location

NCT03271463 is a study of Chronic Stroke that has completed, run by University of Minnesota. The registered enrollment target is 16 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03271463, a study of Chronic Stroke, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the clinometric (psychometric) properties of the SCALE and FMA-LE assessments in adults after stroke. A second purpose is to determine how well each measure predicts walking speed using the 10 meter walk test.

Conditions Studied

Interventions

  • BEHAVIORAL Selective Control Assessment of Lower Extremity (SCALE)

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2018-08-05
Est. Completion 2020-11-05

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03271463

The ClinicalTrials.gov registry entry for NCT03271463 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (63% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Selective Control Assessment of Lower Extremity (SCALE) is the first listed.

NCT03271463 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03271463 about?

NCT03271463 is a clinical study titled "Assessing Leg Control in People With Chronic Stroke". The purpose of this study is to compare the clinometric (psychometric) properties of the SCALE and FMA-LE assessments in adults after stroke. A second purpose is to determine how well each measure predicts walking speed using the 10 meter walk test.

What is the current status of trial NCT03271463?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2018-08-05. Estimated completion is 2020-11-05.

What conditions does trial NCT03271463 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT03271463?

The interventions under investigation include: Selective Control Assessment of Lower Extremity (SCALE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03271463?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03271463 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.